A similar duplication was previously reported in 10 Caribbean Hispanic AD cases and 3 controls, with dosage increase of CYFIP1 and NIPA1 genes confirmed by quantitative PCR [28]. This evidence concerns the gene NIPA1 and Alzheimer disease.